Brief: Ryvu Therapeutics Signs EUR 4 Mln Financial Support Deal For 'Remark' Study
20/10/2023 06:40
Oct 20 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SIGNS FINANCIAL SUPPORT DEAL WITH GCP-SERVICE
INTERNATIONAL WEST
GMBH AND UWE PLATZBECKER
* DEAL FOR 'REMARK' CLINICAL STUDY
* EST. LEVEL OF FUNDING FROM RYVU AT ABOUT EUR 4 MILLION
Source text for Eikon: ID:nEM8V9y1ca
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys